Spironolactone: all 176 studies that test it
Page 2 of 2. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- Evaluating the Effect of Spironolactone on Hypertrophic CardiomyopathyStatus unknownNCT02948998Phase 4
- Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial HypertensionCompletedNCT02832973Phase 4
- Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial FibrillationStatus unknownNCT02764619Phase 3
- Spironolactone in Atrial FibrillationStatus unknownNCT02673463Phase 4
- Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer PatientsStatus unknownNCT02531412Phase 2/3
- Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKDStatus unknownNCT02502981Phase 4
- Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)TerminatedNCT02501213Phase 2
- The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic AlopeciaWithdrawnNCT02483195Phase 4
- High-Dose Aldactone for Treatment of Diuretic Resistant Heart FailureWithdrawnNCT02429388Phase 4
- Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant HypertensionCompletedNCT02426099Phase 4
- Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac SurgeryStatus unknownNCT02417896Not applicable
- Optimum Treatment for Drug-Resistant HypertensionStatus unknownNCT02369081Phase 4
- Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety StudyWithdrawnNCT02299726Phase 2
- Residual Renal Function Preservation in Peritoneal Dialysis PatientsStatus unknownNCT02190318Not applicable
- Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in HumanCompletedNCT02129621Not applicable
- Spironolactone Against Anthracycline-induced CardiomyopathyCompletedNCT02053974Phase 4
- A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)WithdrawnNCT02047422Not applicable
- The Effect of Spironolactone on Pain in Older People With OsteoarthritisCompletedNCT02046668Phase 4
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With NormoalbuminuriaCompletedNCT02040441Phase 2/3
- Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing HeartCompletedNCT01944384Phase 4
- L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRDWithdrawnNCT01855334Phase 4
- ALdosterone Antagonist Chronic HEModialysis Interventional Survival TrialCompletedNCT01848639Phase 3
- Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin BTerminatedNCT01843309Phase 4
- A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)WithdrawnNCT01817803Not applicable
- Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung DiseaseStatus unknownNCT01721655Phase 2/3
- Mineralocorticoid Receptor Antagonists in End Stage Renal DiseaseCompletedNCT01691053Phase 2
- Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis PatientsCompletedNCT01687699Phase 4
- Resistant Hypertension Optimal TreatmentStatus unknownNCT01643434Phase 4
- The Effects of Spironolactone on Calcineurin Inhibitor Induced NephrotoxicityCompletedNCT01602861Phase 4
- Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous ChorioretinitisCompletedNCT01552044Phase 1/2
- Spironolactone Plus Metformin in Polycystic Ovary SyndromeCompletedNCT01526616Not applicable
- Mineralocorticoid Receptor Antagonist and Kidney Allograft HistologyStatus unknownNCT01510795Phase 4
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial HypertensionStatus unknownNCT01468571Phase 4
- Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal AtrophyCompletedNCT01407471Phase 2
- The Effect of Amiloride and Spironolactone in Patients With HypertensionCompletedNCT01388088Phase 4
- Recurrent Stroke Prevention Clinical Outcome StudyStatus unknownNCT01198496Phase 4
- The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesCompletedNCT01195805Not applicable
- Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01147523Phase 2
- Effects of Spironolactone in DialysisStatus unknownNCT01128101Phase 4
- Effect of Aldosterone Blockade on Arterial ComplianceCompletedNCT01089309Phase 4
- Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg TabletsCompletedNCT01083290Phase 1
- Aldosterone Blockade Early After Acute Myocardial InfarctionCompletedNCT01059136Phase 3
- Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant RecipientsSuspendedNCT01021943Phase 2
- Aldosterone in Diabetic NephropathyStatus unknownNCT00870402Phase 4
- Importance of Aldosterone in the Pathogenesis of Hypertensive Heart DiseaseCompletedNCT00865501Phase 3
- Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal DialysisCompletedNCT00865449Phase 3
- Hemodynamic Effects of Spironolactone in Patients With Heart FailureCompletedNCT00860340Not applicable
- The Effect of Amiloride and Spironolactone in Healthy PersonsCompletedNCT00857909Phase 1
- Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) WomenCompletedNCT00842140Not applicable
- Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular FailureWithdrawnNCT00811486Not applicable
- Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)CompletedNCT00741663Phase 4
- Spironolactone Versus Amiloride as an Add on Agent in Resistant HypertensionWithdrawnNCT00709137Not applicable
- Spironolactone for Paroxysmal Atrial FibrillationStatus unknownNCT00689598Not applicable
- Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)CompletedNCT00664222Phase 4
- Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart FailureCompletedNCT00663195Phase 4
- SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)CompletedNCT00604006Phase 3
- Left Ventricular Hypertrophy and Spironolactone in End Stage Renal DiseaseWithdrawnNCT00548912Phase 4
- Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone SystemCompletedNCT00528385Not applicable
- Addition of Spironolactone in Patients With Resistant Arterial HypertensionStatus unknownNCT00524615Phase 4
- Aldosterone Blockade in Heart FailureCompletedNCT00523757Phase 3
- Spironolactone for Reducing Proteinuria in Diabetic NephropathyCompletedNCT00498537Not applicable
- The Efficacy of Spironolactone in Patients With Resistant HypertensionTerminatedNCT00430794Phase 2
- Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone TherapyCompletedNCT00335413Phase 4
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver CirrhosisStatus unknownNCT00332904Phase 4
- Spironolactone Safety in Dialysis PatientsWithdrawnNCT00328809Phase 4
- Spironolactone in Diabetic NephropathyCompletedNCT00317954Phase 4
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?CompletedNCT00291720Phase 2
- Cardiovascular Protective Effect of Spironolactone in HemodialysisStatus unknownNCT00277693Phase 4
- Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides DiureticsCompletedNCT00276289Not applicable
- Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic AlcoholicsSuspendedNCT00226109Phase 4
- Novel Treatment for Diastolic Heart Failure in WomenCompletedNCT00206232Phase 4
- Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair LossCompletedNCT00175617Phase 2
- Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic CardiomyopathyTerminatedNCT00125437Not applicable
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyCompletedNCT00106561Phase 2/3
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans SyndromeCompletedNCT00004311Phase 2
- Treatment of Boys With Precocious PubertyCompletedNCT00001202Phase 2